A normal fasting glucose does not always mean normal metabolic health. During early insulin resistance, the pancreas may compensate by producing more insulin, keeping glucose deceptively normal. Measuring fasting insulin alongside glucose may reveal this hidden metabolic stress earlier. Learn why fasting insulin, HOMA-IR, A1c, triglycerides, waist circumference, and other markers can provide a more complete picture of insulin resistance and metabolic health.

Atherogenic dyslipidemia—marked by high triglycerides, low HDL, and small dense LDL—often hides behind normal LDL cholesterol. This insulin-resistant lipid pattern predicts cardiovascular disease earlier and more accurately than LDL alone.

Hyperinsulinemia often precedes diabetes by decades, quietly driving heart disease, weight gain, hypertension, fatty liver disease, and accelerated aging—even when glucose levels appear normal. Early detection shifts care from reactive treatment to true prevention.